Vaishnavi Muthu - Concepedia

Author

Vaishnavi Muthu

Also Known As

V. Muthu, Vaishnavi Muthu, Vasanth Pandian Thommai Antony Savari Muthu -, Vasanth Pandian Thommai Antony Savari Muthu -

Publications

178

Citations

H-Index

Concepts

All Affiliations

Vaishnavi Muthu is an author at National University Cancer Institute, Singapore specializing in medicine, radiation oncology, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	68
2	Gastroenterology	1	1	40
3	Immunology	1	1	28
4	Surgical Oncology	1	1	40
5	Cancer Therapeutics	1	1	40

Vaishnavi Muthu

Publications

165

Citations

H-Index

Page 1

	Year	Citations
Bitten by a bug or a bag? Transfusion‐transmitted dengue: a rare complication in the bleeding surgical patient Han Boon Oh, Vaishnavi Muthu, Zubin J. Daruwalla, Transfusion	2015	41
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases Daryl Kai Ann Chia, Raghav Sundar, Guowei Kim, Annals of Surgical Oncology Surgical OncologyGastrointestinal OncologyMedicineCancer ManagementGastroenterology	2022	40
Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre Gloria HJ Chan, Yong Xiang Gwee, Jia Li Low, Lung Cancer Single Asian CentrePulmonary TuberculosisCancer ImmunosurveillanceMedicineImmunology	2020	28
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience Joseph J. Zhao, Nesaretnam Barr Kumarakulasinghe, Vaishnavi Muthu, Oncology	2021	25
Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia Jia Li Low, Elaine Hsuen Lim, Lavina Bharwani, Therapeutic Advances in Medical Oncology	2022	19
Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors—Navigating the Radiologic Potpourri Alvin Wong, Balamurugan Vellayappan, Lenith Tai Jit Cheng, Cancers	2021	12

Page 1